Barth, Sarah
Edwards, Colin
Saini, Gauri
Haider, Yussef
Williams, Nicholas Paul
Storrar, Will
Jenkins, Gisli
Stewart, Iain
Wickremasinghe, Melissa
Article History
Received: 16 August 2023
Accepted: 23 March 2024
First Online: 15 April 2024
Declarations
:
: The study received ethical approval from the East Midlands-Derby Research Ethics Committee and the Health Research Authority. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. All participants provided informed consent.
: CE is a shareholder and former employee of patientMpower Ltd. GJ has received grants to his institution from AstraZeneca, Biogen, Galecto, GSK, Nordic Biosciences, RedX, and Pilant. He reports consultancy fees from AstraZeneca, Brainomix, Bristol Myers Squibb, Chiesi, Cohbar, Daewoong, Galecto, GSK, Pliant, Resolution Therapeutics, Roche, and Veracyte, and lecture fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Roche, and PatientMPower. GJ is on data safety monitoring boards for Boehringer Ingelheim, Galapagos, and Vicore, and is on the advisory board of NuMedii. GJ is the current president of Action for Pulmonary Fibrosis. MW is a medical advisor to patientMpower Ltd and QuReight Ltd. She has received a grant to her institution from patientMpower Ltd for the purpose of this research study. She reports consultancy and lecture fees from Boehringer Ingelheim, Roche and patientMpower Ltd. MW is the CCIO for personal health records (patient portal) at ICHNT.